Zbigniew Konopski
Position:
Phone:
Email:
 

Author network for Zbigniew Konopski by COREMINE medical


Publications 2016

Midgard H, Bjøro B, Mæland A, Konopski Z, Kileng H, Damås JK, Paulsen J, Heggelund L, Sandvei PK, Ringstad JO, Karlsen LN, Stene-Johansen K, Pettersson JH, Dorenberg DH, Dalgard O (2016)
Hepatitis C reinfection after sustained virological response
J Hepatol, 64 (5), 1020-6
PubMed 26780289

Publications 2015

Hauge T, Hauge PW, Warloe T, Drolsum A, Johansen C, Viktil E, Aabakken L, Buanes T, Konopski Z (2015)
Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study
Photodiagnosis Photodyn Ther, 13, 330-3
PubMed 26415549

Otterdal K, Haukeland JW, Yndestad A, Dahl TB, Holm S, Segers FM, Gladhaug IP, Konopski Z, Damås JK, Halvorsen B, Aukrust P (2015)
Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation
Clin Transl Gastroenterol, 6, e95
PubMed 26133108

Publications 2012

Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Løberg EM, Haukeland JW (2012)
Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver
Scand J Gastroenterol, 48 (1), 93-100
PubMed 23205894

Publications 2011

Andersen ES, Weiland O, Leutscher P, Krarup H, Westin J, Moessner B, Konopski Z, Frigstad SO, Kjaer M, Christensen PB, Weis N (2011)
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs
Scand. J. Gastroenterol., 46 (6), 760-766

Florholmen J, Kristiansen MG, Steigen SE, Sorbye SW, Paulssen EJ, Kvamme JM, Konopski Z, Gutteberg T, Goll R (2011)
A rapid chemokine response of macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C
Clin. Microbiol. Infect., 17 (2), 204-209

Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2011)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol, 166 (3), 503-10
PubMed 22170794

Publications 2010

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damås JK, Haaland T, Løberg EM, Arntsen B, Birkeland K, Bjøro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
PubMed 20392873

Publications 2009

Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
PubMed 19811343

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
PubMed 19532130

Publications 2008

Haukeland JW, Schreiner LT, Lorgen I, Frigstad SO, Bang C, Raknerud N, Konopski Z (2008)
ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis
Scand. J. Gastroenterol., 43 (10), 1241-1248

Publications 2007

Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjøro K, Bang C, Raknerud N, Konopski Z (2007)
Incidence rates and causes of cirrhosis in a Norwegian population
Scand J Gastroenterol, 42 (12), 1501-8
PubMed 17852839

Moum B, Konopski Z, Tufteland KF, Jahnsen J (2007)
Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab
Inflamm Bowel Dis, 13 (12), 1584-6
PubMed 17663423

Publications 2006

Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
PubMed 16618517

Publications 2005

Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Løberg E, Haaland T, Birkeland K, Bjøro K (2005)
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Scand J Gastroenterol, 40 (12), 1469-77
PubMed 16293559

Publications 1994

Busund R, Rønning G, Lindsetmo RO, Busund LT, Mollnes TE, Konopski Z, Revhaug A (1994)
The effects of plasma and albumin infusion on organ function and sepsis markers in experimental gram-negative sepsis
Shock, 2 (6), 402-7
PubMed 7743369

REKDAL O, KONOPSKI Z, SVENDSEN JS, WINBERG JO, ESPEVIK T, OSTERUD B (1994)
THE TNF RECEPTORS P55 AND P75 MEDIATE CHEMOTAXIS OF PMN INDUCED BY TNF-ALPHA AND A TNF-ALPHA-36-62 PEPTIDE
Mediat. Inflamm., 3 (5), 347-352